I am Sanxing, a future graduate from the University of Hong Kong, set to complete my studies in 2025. My academic journey has been deeply rooted in the field of cancer immunotherapy, with a particular focus on enhancing infiltration and immune priming for solid tumors, specifically liver cancer. Recently, I had the privilege of contributing to a project on Chimeric Antigen Receptor T Cell (CAR-T) Therapy for Melanoma at SUSTech. This experience has further fueled my passion for advancing cancer treatments. My research is currently centered on harmonizing different immune cells to effectively tackle liver cancer. I am particularly interested in deciphering cell-cell communication using single-cell RNA sequencing and spatial transcriptomics. I am eager to explore potential synergies between my research and clinical trials. I look forward to the possibility of pushing the boundaries of science and technology.